Global Interchangeable Biological Products Market Research Report 2024

Publication ID:

PB505243526

Publication Date:

May 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

An interchangeable biosimilar is a biosimilar that meets additional requirements outlined by the law that allows for the FDA to approve biosimilar and interchangeable biosimilar medications.An interchangeable biosimilar product may be substituted for the original product without consulting the prescriber, much like how generic drugs are routinely substituted for brand name drugs. This is commonly called pharmacy-level substitution and is subject to state pharmacy laws.
The global Interchangeable Biological Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Interchangeable Biological Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interchangeable Biological Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Interchangeable Biological Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Interchangeable Biological Products include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interchangeable Biological Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interchangeable Biological Products.
The Interchangeable Biological Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interchangeable Biological Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interchangeable Biological Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Segment by Type
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interchangeable Biological Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interchangeable Biological Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Interchangeable Biological Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interchangeable Biological Products Market Perspective (2019-2030)
2.2 Global Interchangeable Biological Products Growth Trends by Region
2.2.1 Global Interchangeable Biological Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Interchangeable Biological Products Historic Market Size by Region (2019-2024)
2.2.3 Interchangeable Biological Products Forecasted Market Size by Region (2025-2030)
2.3 Interchangeable Biological Products Market Dynamics
2.3.1 Interchangeable Biological Products Industry Trends
2.3.2 Interchangeable Biological Products Market Drivers
2.3.3 Interchangeable Biological Products Market Challenges
2.3.4 Interchangeable Biological Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interchangeable Biological Products Players by Revenue
3.1.1 Global Top Interchangeable Biological Products Players by Revenue (2019-2024)
3.1.2 Global Interchangeable Biological Products Revenue Market Share by Players (2019-2024)
3.2 Global Interchangeable Biological Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Interchangeable Biological Products Revenue
3.4 Global Interchangeable Biological Products Market Concentration Ratio
3.4.1 Global Interchangeable Biological Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interchangeable Biological Products Revenue in 2023
3.5 Global Key Players of Interchangeable Biological Products Head office and Area Served
3.6 Global Key Players of Interchangeable Biological Products, Product and Application
3.7 Global Key Players of Interchangeable Biological Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Interchangeable Biological Products Breakdown Data by Type
4.1 Global Interchangeable Biological Products Historic Market Size by Type (2019-2024)
4.2 Global Interchangeable Biological Products Forecasted Market Size by Type (2025-2030)
5 Interchangeable Biological Products Breakdown Data by Application
5.1 Global Interchangeable Biological Products Historic Market Size by Application (2019-2024)
5.2 Global Interchangeable Biological Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Interchangeable Biological Products Market Size (2019-2030)
6.2 North America Interchangeable Biological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Interchangeable Biological Products Market Size by Country (2019-2024)
6.4 North America Interchangeable Biological Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interchangeable Biological Products Market Size (2019-2030)
7.2 Europe Interchangeable Biological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Interchangeable Biological Products Market Size by Country (2019-2024)
7.4 Europe Interchangeable Biological Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interchangeable Biological Products Market Size (2019-2030)
8.2 Asia-Pacific Interchangeable Biological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Interchangeable Biological Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Interchangeable Biological Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interchangeable Biological Products Market Size (2019-2030)
9.2 Latin America Interchangeable Biological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Interchangeable Biological Products Market Size by Country (2019-2024)
9.4 Latin America Interchangeable Biological Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interchangeable Biological Products Market Size (2019-2030)
10.2 Middle East & Africa Interchangeable Biological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Interchangeable Biological Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Interchangeable Biological Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Interchangeable Biological Products Introduction
11.1.4 Roche Revenue in Interchangeable Biological Products Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Interchangeable Biological Products Introduction
11.2.4 Amgen Revenue in Interchangeable Biological Products Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Interchangeable Biological Products Introduction
11.3.4 AbbVie Revenue in Interchangeable Biological Products Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Interchangeable Biological Products Introduction
11.4.4 Sanofi Revenue in Interchangeable Biological Products Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Interchangeable Biological Products Introduction
11.5.4 Johnson & Johnson Revenue in Interchangeable Biological Products Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Interchangeable Biological Products Introduction
11.6.4 Pfizer Revenue in Interchangeable Biological Products Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Interchangeable Biological Products Introduction
11.7.4 Novo Nordisk Revenue in Interchangeable Biological Products Business (2019-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Interchangeable Biological Products Introduction
11.8.4 Eli Lilly Revenue in Interchangeable Biological Products Business (2019-2024)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Interchangeable Biological Products Introduction
11.9.4 Novartis Revenue in Interchangeable Biological Products Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Interchangeable Biological Products Introduction
11.10.4 Merck Revenue in Interchangeable Biological Products Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Biogen
11.11.1 Biogen Company Details
11.11.2 Biogen Business Overview
11.11.3 Biogen Interchangeable Biological Products Introduction
11.11.4 Biogen Revenue in Interchangeable Biological Products Business (2019-2024)
11.11.5 Biogen Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Details
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Interchangeable Biological Products Introduction
11.12.4 Celltrion Revenue in Interchangeable Biological Products Business (2019-2024)
11.12.5 Celltrion Recent Development
11.13 Sobi
11.13.1 Sobi Company Details
11.13.2 Sobi Business Overview
11.13.3 Sobi Interchangeable Biological Products Introduction
11.13.4 Sobi Revenue in Interchangeable Biological Products Business (2019-2024)
11.13.5 Sobi Recent Development
11.14 3SBIO
11.14.1 3SBIO Company Details
11.14.2 3SBIO Business Overview
11.14.3 3SBIO Interchangeable Biological Products Introduction
11.14.4 3SBIO Revenue in Interchangeable Biological Products Business (2019-2024)
11.14.5 3SBIO Recent Development
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Details
11.15.2 Changchun High Tech Business Overview
11.15.3 Changchun High Tech Interchangeable Biological Products Introduction
11.15.4 Changchun High Tech Revenue in Interchangeable Biological Products Business (2019-2024)
11.15.5 Changchun High Tech Recent Development
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Details
11.16.2 Kanghong Pharma Business Overview
11.16.3 Kanghong Pharma Interchangeable Biological Products Introduction
11.16.4 Kanghong Pharma Revenue in Interchangeable Biological Products Business (2019-2024)
11.16.5 Kanghong Pharma Recent Development
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Details
11.17.2 Innovent Biologics Business Overview
11.17.3 Innovent Biologics Interchangeable Biological Products Introduction
11.17.4 Innovent Biologics Revenue in Interchangeable Biological Products Business (2019-2024)
11.17.5 Innovent Biologics Recent Development
11.18 Gan&Lee
11.18.1 Gan&Lee Company Details
11.18.2 Gan&Lee Business Overview
11.18.3 Gan&Lee Interchangeable Biological Products Introduction
11.18.4 Gan&Lee Revenue in Interchangeable Biological Products Business (2019-2024)
11.18.5 Gan&Lee Recent Development
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Details
11.19.2 Tonghua Dongbao Business Overview
11.19.3 Tonghua Dongbao Interchangeable Biological Products Introduction
11.19.4 Tonghua Dongbao Revenue in Interchangeable Biological Products Business (2019-2024)
11.19.5 Tonghua Dongbao Recent Development
11.20 United Laboratory
11.20.1 United Laboratory Company Details
11.20.2 United Laboratory Business Overview
11.20.3 United Laboratory Interchangeable Biological Products Introduction
11.20.4 United Laboratory Revenue in Interchangeable Biological Products Business (2019-2024)
11.20.5 United Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂